Global nuclear medicine market is estimated to grow at a rate of 2% during the forecast period owing to increasing incidence and prevalence of diseases like cancer, initiatives to reduce the demand and supply gap of Mo-99 and increasing research and development activities in radiotherapy to treat various diseases. Furthermore, nuclear medicines are extensively being used in molecular imaging, which is a technique involving molecules as biomarkers for specific molecular processes that determines the onset or progress of a disease.

Nuclear medicines are convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices. Due to this major factor, chemotherapy methods are being replaced by radiopharmaceuticals or nuclear medicines for cancer treatment. They are also used in applications such as lymphoma and bone metastasis. Some of the nuclear medicines used in diagnostic procedures are F-18, Tc-99, Ga-67, and I-123 while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223 are used in therapeutics procedures. These factors are anticipated to drive global nuclear medicine market until 2025.

Apart from above mentioned growth factors, the global nuclear medicine market also faces some restrains. Short half-life of nuclear medicines or radiopharmaceuticals reduces their potential adoption. Other restraining factors include supply shortages, logistical difficulties, and limited number of trained medical personnel.

The global nuclear medicine market is segmented based on therapy, type, application, therapeutics, route of administration, end-user and region. Based on application, the global nuclear medicine market is segmented into cardiology, respiratory, orthopaedics, neurology, oncology and urology. Among them, the oncology segment accounts for the major market share due to increasing prevalence of cancer worldwide. Based on type, the nuclear medicine market is segmented into SPECT, PET. The PET segment accounts for 80% of the oncology market whereas SPECT contributing majorly for other applications like cardiology, nephrology and neuroendocrine.

Major players operating in the global nuclear medicine market include Cardinal Health, Curium, Lantheus, Bracco, Advanced Accelerator Applications, NTP Radioisotopes, Eckert & Ziegler, Jubilant DraxImage, GE Healthcare, Siemens Healthineers, Rotem Industries, Eczacibasi-Monrol, IBA Group, Ire-Elit, Lucerno Dynamics, Positron Corporation, NorthStar Medical Radioisotopes, Pharmalucence, Norgine, Roche and others. Key market players are implementing activities like product developments, business expansion, and collaborative development to maintain significant share in the market for nuclear medicine.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

·         To analyze and forecast the market size of global nuclear medicine market.

·         To classify and forecast global nuclear medicine market based on therapy, type, application, therapeutics, route of administration, end-user, company and regional distribution.

·         To identify drivers and challenges for global nuclear medicine market.

·         To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global nuclear medicine market.

·         To conduct pricing analysis for global nuclear medicine market.

·         To identify and analyze the profile of leading players operating in global nuclear medicine market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global nuclear medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

·         Nuclear medicine manufacturer, suppliers, distributors and other stakeholders

·         Hospitals & Clinics

·         Government bodies such as regulating authorities and policy makers

·         Organizations, forums and alliances related to nuclear medicine

·         Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global nuclear medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Market, By Therapy:

o   Radioactive Iodine

o   Radioactive Antibodies

o   Radioactive Phosphorus

o   Others

·         Market, By Type:

o   SPECT (Single Photo Emission Computed Tomography)

o   PET (Positron Emission Tomography)

·         Market, By Application:

o   Cardiology

o   Respiratory

o   Orthopaedics

o   Neurology

o   Oncology

o   Urology

·         Market, By Therapeutics:

o   Alpha Particle Emitters

o   Beta Particle Emitters

o   Auger Electron Emitters

·         Market, By Route of Administration:

o   Oral

o   Intravenous

o   Nasal

·         Market, By End-User:

o   Hospitals

o   Diagnostic Centers

o   Others

·         Market, By Region:

o   Asia-Pacific

o   Europe

o   North America

o   South America

o   Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nuclear medicine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

·         Detailed analysis and profiling of additional market players (up to five).

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Voice of Customer

5.    Global Nuclear Medicine Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Therapy (Radioactive Iodine, Radioactive Antibodies, Radioactive Phosphorus, Others

5.2.2.     By Type (SPECT (Single photo emission computed tomography), PET (Positron emission tomography))

5.2.3.     By Application (Cardiology, Respiratory, Orthopaedics, Neurology, Oncology, Urology)

5.2.4.     By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Auger Electron Emitters)

5.2.5.     By Route of Administration (Oral, Intravenous, Nasal)

5.2.6.     By End-User (Hospitals, Diagnostic centers, Others)

5.2.7.     By Company (2019)

5.2.8.     By Region

5.3.  Market Attractiveness Index

6.    Asia-Pacific Nuclear Medicine Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Therapy

6.2.2.     By Type

6.2.3.     By Application

6.2.4.     By Therapeutics

6.2.5.     By Route of Administration

6.2.6.     By End-User

6.2.7.     By Country

6.3.  Market Attractiveness Index

6.4.  Asia-Pacific: Country Analysis

6.4.1.     China Nuclear Medicine Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Therapy

6.4.1.2.2.             By Type

6.4.1.2.3.             By Application

6.4.1.2.4.             By Therapeutics

6.4.1.2.5.             By Route of Administration

6.4.1.2.6.             By End-User

6.4.2.     India Nuclear Medicine Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Therapy

6.4.2.2.2.             By Type

6.4.2.2.3.             By Application

6.4.2.2.4.             By Therapeutics

6.4.2.2.5.             By Route of Administration

6.4.2.2.6.             By End-User

6.4.3.     Japan Nuclear Medicine Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Therapy

6.4.3.2.2.             By Type

6.4.3.2.3.             By Application

6.4.3.2.4.             By Therapeutics

6.4.3.2.5.             By Route of Administration

6.4.3.2.6.             By End-User

6.4.4.     South Korea Nuclear Medicine Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Therapy

6.4.4.2.2.             By Type

6.4.4.2.3.             By Application

6.4.4.2.4.             By Therapeutics

6.4.4.2.5.             By Route of Administration

6.4.4.2.6.             By End-User

6.4.5.     Singapore Nuclear Medicine Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Therapy

6.4.5.2.2.             By Type

6.4.5.2.3.             By Application

6.4.5.2.4.             By Therapeutics

6.4.5.2.5.             By Route of Administration

6.4.5.2.6.             By End-User

6.4.6.     Australia Nuclear Medicine Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Therapy

6.4.6.2.2.             By Type

6.4.6.2.3.             By Application

6.4.6.2.4.             By Therapeutics

6.4.6.2.5.             By Route of Administration

6.4.6.2.6.             By End-User

7.    Europe Nuclear Medicine Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Therapy

7.2.2.     By Type

7.2.3.     By Application

7.2.4.     By Therapeutics

7.2.5.     By Route of Administration

7.2.6.     By End-User

7.2.7.     By Country

7.3.  Market Attractiveness Index

7.4.  Europe: Country Analysis

7.4.1.     France Nuclear Medicine Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Therapy

7.4.1.2.2.             By Type

7.4.1.2.3.             By Application

7.4.1.2.4.             By Therapeutics

7.4.1.2.5.             By Route of Administration

7.4.1.2.6.             By End-User

7.4.2.     Germany Nuclear Medicine Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Therapy

7.4.2.2.2.             By Type

7.4.2.2.3.             By Application

7.4.2.2.4.             By Therapeutics

7.4.2.2.5.             By Route of Administration

7.4.2.2.6.             By End-User

7.4.3.     United Kingdom Nuclear Medicine Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Therapy

7.4.3.2.2.             By Type

7.4.3.2.3.             By Application

7.4.3.2.4.             By Therapeutics

7.4.3.2.5.             By Route of Administration

7.4.3.2.6.             By End-User

7.4.4.     Italy Nuclear Medicine Market Outlook

7.4.4.1.         Market Size & Forecast

7.4.4.1.1.             By Value

7.4.4.2.         Market Share & Forecast

7.4.4.2.1.             By Therapy

7.4.4.2.2.             By Type

7.4.4.2.3.             By Application

7.4.4.2.4.             By Therapeutics

7.4.4.2.5.             By Route of Administration

7.4.4.2.6.             By End-User

7.4.5.     Russia Nuclear Medicine Market Outlook

7.4.5.1.         Market Size & Forecast

7.4.5.1.1.             By Value

7.4.5.2.         Market Share & Forecast

7.4.5.2.1.             By Therapy

7.4.5.2.2.             By Type

7.4.5.2.3.             By Application

7.4.5.2.4.             By Therapeutics

7.4.5.2.5.             By Route of Administration

7.4.5.2.6.             By End-User

7.4.6.     Spain Nuclear Medicine Market Outlook

7.4.6.1.         Market Size & Forecast

7.4.6.1.1.             By Value

7.4.6.2.         Market Share & Forecast

7.4.6.2.1.             By Therapy

7.4.6.2.2.             By Type

7.4.6.2.3.             By Application

7.4.6.2.4.             By Therapeutics

7.4.6.2.5.             By Route of Administration

7.4.6.2.6.             By End-User

8.    North America Nuclear Medicine Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Therapy

8.2.2.     By Type

8.2.3.     By Application

8.2.4.     By Therapeutics

8.2.5.     By Route of Administration

8.2.6.     By End-User

8.2.7.     By Country

8.3.  Market Attractiveness Index

8.4.  North America: Country Analysis

8.4.1.     United States Nuclear Medicine Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Therapy

8.4.1.2.2.             By Type

8.4.1.2.3.             By Application

8.4.1.2.4.             By Therapeutics

8.4.1.2.5.             By Route of Administration

8.4.1.2.6.             By End-User

8.4.2.     Mexico Nuclear Medicine Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Therapy

8.4.2.2.2.             By Type

8.4.2.2.3.             By Application

8.4.2.2.4.             By Therapeutics

8.4.2.2.5.             By Route of Administration

8.4.2.2.6.             By End-User

8.4.3.     Canada Nuclear Medicine Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Therapy

8.4.3.2.2.             By Type

8.4.3.2.3.             By Application

8.4.3.2.4.             By Therapeutics

8.4.3.2.5.             By Route of Administration

8.4.3.2.6.             By End-User

9.    South America Nuclear Medicine Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Therapy

9.2.2.     By Type

9.2.3.     By Application

9.2.4.     By Therapeutics

9.2.5.     By Route of Administration

9.2.6.     By End-User

9.2.7.     By Country

9.3.  Market Attractiveness Index

9.4.  South America: Country Analysis

9.4.1.     Brazil Nuclear Medicine Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Therapy

9.4.1.2.2.             By Type

9.4.1.2.3.             By Application

9.4.1.2.4.             By Therapeutics

9.4.1.2.5.             By Route of Administration

9.4.1.2.6.             By End-User

9.4.2.     Argentina Nuclear Medicine Market Outlook

9.4.2.1.         Market Size & Forecast

9.4.2.1.1.             By Value

9.4.2.2.         Market Share & Forecast

9.4.2.2.1.             By Therapy

9.4.2.2.2.             By Type

9.4.2.2.3.             By Application

9.4.2.2.4.             By Therapeutics

9.4.2.2.5.             By Route of Administration

9.4.2.2.6.             By End-User

9.4.3.     Colombia Nuclear Medicine Market Outlook

9.4.3.1.         Market Size & Forecast

9.4.3.1.1.             By Value

9.4.3.2.         Market Share & Forecast

9.4.3.2.1.             By Therapy

9.4.3.2.2.             By Type

9.4.3.2.3.             By Application

9.4.3.2.4.             By Therapeutics

9.4.3.2.5.             By Route of Administration

9.4.3.2.6.             By End-User

10.  Middle East and Africa Nuclear Medicine Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Therapy

10.2.2.  By Type

10.2.3.  By Application

10.2.4.  By Therapeutics

10.2.5.  By Route of Administration

10.2.6.  By End-User

10.2.7.  By Country

10.3.              Market Attractiveness Index

10.4.              MEA: Country Analysis

10.4.1.  South Africa Nuclear Medicine Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Therapy

10.4.1.2.2.           By Type

10.4.1.2.3.           By Application

10.4.1.2.4.           By Therapeutics

10.4.1.2.5.           By Route of Administration

10.4.1.2.6.           By End-User

10.4.2.  Saudi Arabia Nuclear Medicine Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Therapy

10.4.2.2.2.           By Type

10.4.2.2.3.